Hardman Johnston Global Advisors LLC Acquires 1,360 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Hardman Johnston Global Advisors LLC raised its stake in IQVIA Holdings Inc. (NYSE:IQV) by 0.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 229,055 shares of the medical research company’s stock after purchasing an additional 1,360 shares during the period. IQVIA accounts for approximately 2.1% of Hardman Johnston Global Advisors LLC’s investment portfolio, making the stock its 15th biggest position. Hardman Johnston Global Advisors LLC’s holdings in IQVIA were worth $54,279,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. First Foundation Advisors grew its stake in shares of IQVIA by 3.8% in the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock valued at $245,000 after acquiring an additional 43 shares in the last quarter. Team Hewins LLC grew its position in shares of IQVIA by 5.0% during the 1st quarter. Team Hewins LLC now owns 973 shares of the medical research company’s stock worth $246,000 after purchasing an additional 46 shares in the last quarter. Invera Wealth Advisors LLC increased its holdings in shares of IQVIA by 0.3% during the second quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after purchasing an additional 46 shares during the period. Covestor Ltd raised its position in shares of IQVIA by 45.3% in the first quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock valued at $39,000 after buying an additional 48 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its stake in shares of IQVIA by 0.3% in the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock valued at $3,313,000 after buying an additional 48 shares during the period. Institutional investors and hedge funds own 89.62% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on IQV. Jefferies Financial Group downgraded IQVIA from a “buy” rating to a “hold” rating and cut their target price for the company from $266.00 to $242.00 in a research report on Wednesday, July 24th. TD Cowen cut their price objective on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research report on Friday, November 1st. StockNews.com raised shares of IQVIA from a “hold” rating to a “buy” rating in a report on Wednesday, October 30th. Truist Financial cut their price target on shares of IQVIA from $286.00 to $265.00 and set a “buy” rating for the company in a report on Monday. Finally, BTIG Research reduced their price target on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $259.13.

IQVIA Stock Performance

Shares of IQV stock opened at $212.96 on Wednesday. The business’s 50-day moving average price is $232.84 and its 200-day moving average price is $229.54. The firm has a market capitalization of $38.65 billion, a price-to-earnings ratio of 27.95, a PEG ratio of 2.07 and a beta of 1.51. IQVIA Holdings Inc. has a 12 month low of $190.20 and a 12 month high of $261.73. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76.

Insiders Place Their Bets

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the completion of the sale, the insider now owns 19,536 shares of the company’s stock, valued at approximately $4,812,302.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.